Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patients

: Basnyat P, Hagman S, Kolasa M, Koivisto K, Verkkoniemi-Ahola A, Airas L, Elovaara I

Publisher: ELSEVIER SCI LTD

: 2015

: Multiple Sclerosis and Related Disorders

: MULTIPLE SCLEROSIS AND RELATED DISORDERS

: MULT SCLER RELAT DIS

: 4

: 334

: 338

: 5

: 2211-0348

DOI: https://doi.org/10.1016/j.msard.2015.06.008

Conclusion: The results support the hypothesis of sL-selectin being connected to the anti-JCV antibody index values and possibly cellular L-selectin. Measurement of serum sL-selectin should be evaluated further as a potential biomarker for predicting the risk of developing PML. (C) 2015 Elsevier B.V. All rights reserved.